Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
71,941,794
-
Number of holders
-
316
-
Total 13F shares, excl. options
-
69,014,206
-
Shares change
-
-1,232,124
-
Total reported value, excl. options
-
$6,851,742,817
-
Value change
-
-$115,598,904
-
Put/Call ratio
-
1.52%
-
Number of buys
-
135
-
Number of sells
-
-155
-
Price
-
$99.29
Significant Holders of WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) as of Q2 2018
356 filings reported holding WST - WEST PHARMACEUTICAL SERVICES INC - Common Stock as of Q2 2018.
WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) has 316 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 69,014,206 shares
of 71,941,794 outstanding shares and own 95.93% of the company stock.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (9,634,877 shares), VANGUARD GROUP INC (6,928,631 shares), BlackRock Inc. (6,570,782 shares), FRANKLIN RESOURCES INC (4,711,071 shares), Neuberger Berman Group LLC (3,052,340 shares), ALLIANCEBERNSTEIN L.P. (2,678,628 shares), STATE STREET CORP (2,353,270 shares), JPMORGAN CHASE & CO (1,841,530 shares), BAMCO INC /NY/ (1,639,686 shares), and WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (1,628,739 shares).
This table shows the top 316 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.